Clinical Trials Using Axl/Mer Inhibitor ONO-7475

Clinical trials are research studies that involve people. The clinical trials on this list are studying Axl/Mer Inhibitor ONO-7475. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • A Study of ONO-7475 in Patients With Acute Leukemias

    This study will determine the safety and maximum tolerated dose of ONO-7475 in patients with relapsed or refractory acute leukemia or relapsed or refractory myelodysplastic syndromes, and evaluate the efficacy of ONO-7475 in patients with newly diagnosed AML
    Location: 5 locations